Hospital Pharmacy January 2012 Formulary Drug Review: Ticagrelor

Pharmacists and Pharmacy Techs: New CE Requirements. Click here for more info.

- Journal Article -

Hospital Pharmacy - Formulary Drug Review
January 2012 - Ticagrelor

Activity Description

Hospital Pharmacy - Formulary Drug Review Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available online. Monographs can be customized to meet the needs of a facility. Subscribers to The Formulary Monograph Service also receive access to a pharmacy bulletin board, The Formulary Information Exchange (The F.I.X.). All topics pertinent to clinical and hospital pharmacy are discussed on The F.I.X. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service or The F.I.X., call The Formulary at 800-322-4349.

Learning Objectives

Upon completion of this activity, the reader will be able to:

Describe the pharmacology and pharmacokinetics of ticagrelor.
Discuss the risks associated with the use of ticagrelor.
Discuss the potential benefit of ticagrelor for an individual patient.
Apply the information on the use of ticagrelor to a case study.

Faculty

Dennis J. Cada, PharmD, FASHP, FASCP (Editor)
Executive Editor, The Formulary
Facts & Comparisons
Wolters Kluwer

Terri L. Levien, PharmD
Clinical Associate Professor of Pharmacotherapy
Drug Information Center
Washington State University
Spokane, Washington

Danial E. Baker, PharmD, FASHP, FASCP
Director, Drug Information Center
Professor of Pharmacy Practice, College of Pharmacy
Washington State University
Spokane, Washington

Disclosure

It is the policy of ProCE, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Dr. Cada, Dr. Levien, and Dr. Baker have reported that they have no significant financial or commercial relationships to disclose.

Please note: The information and views presented in this CE activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications. Use of drugs and/or devices outside of labeling should be considered experimental. Participants are advised to consult and verify manufacturer product information, the professional literature and use his/her professional judgment in applying the presented information in patient care activities.

CE Accreditation

Pharmacists:
This CE activity is co-sponsored by ProCE, Inc. and Hospital Pharmacy. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-999-12-001-H01-P has been assigned to this knowledge-based home-study CE activity (initial release date 01-01-12). This CE activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of credit will be issued online upon completion of the activity evaluation and the post-test with a score of 70% or higher. No partial credit will be given.

Release Date: 01-01-2012
Expiration Date: 01-01-2014

Funding

This activity is self-funded by Hospital Pharmacy.

To Participate

To participate in this Web-based continuing education activity:
1.	Review the activity description and objectives.
2.	View the activity by clicking on the appropriate link below.
3.	Complete the online post-test and activity evaluation via the ProCE LMS by clicking the hyperlink below (registration will be required).

View this Activity

Read the Formulary Drug Reviews via Hospital Pharmacy:

Post-Test / Evaluation and CE Statement

Existing ProCE LMS Users:
Login to the ProCE LMS to enroll and take the post-test, complete the evaluation, and to obtain your CE statement. Please note that this ProCE account is separate from your Hospital Pharmacy account.

New User:
To set up your account with the ProCE LMS, Click here to register. Please note that your ProCE account is separate from the one you have with Hospital Pharmacy.

Resume or Reprint CE statement:
Click here to resume taking the post-test OR Reprint CE Statement.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Click here for ProCE, Inc.'s Privacy Policy.